The ONE Campaign’s latest analysis reveals that Africa remains heavily reliant on external sources for vaccines, sourcing only 1.1% of its supply domestically. This dependence, primarily on Asia and Europe, exposes the continent to vulnerabilities in vaccine distribution.
In response, the African Union and Africa CDC have set an ambitious target: to produce 60% of Africa’s vaccines locally by 2040. This initiative aims to enhance regional health security and mitigate the risks associated with global supply chain disruptions. Critical Insights from the Analysis: Ndidi Okonkwo Nwuneli, President and CEO of The ONE Campaign, emphasized the imperative of achieving vaccine sovereignty in Africa as the continent’s vaccine demand is set to rise dramatically by 2030.
She called for collaborative efforts and steadfast commitments to overcome existing challenges. France’s Commitment and Global Partnership: The drive for vaccine sovereignty represents a pivotal stride towards equitable healthcare access in Africa, ensuring healthier futures for all communities across the continent..